The Fraunhofer ITEM division Personalized Tumor Therapy will be presented at this year's Annual Congress of the European Association for Cancer Research, EACR.
Meet us at our joint booth with Fraunhofer IIS: booth number 10.
Rotterdam Ahoy
Ahoyweg 10, 3084 BA Rotterdam, Netherlands
June 10, 2024 - June 13, 2024
English
We have developed a Platform for Ex-Vivo Drug Response Assays (PEDRA) that mirrors the clinical patient situation in vitro by using disease-specific models generated from clinical samples, recruited individually for each project. PEDRA comprises several ex-vivo assays of variable cellular complexity. In combination with state-of-the-art readouts drug safety and efficacy can be assessed for a broad range of anticancer treatments. Because PEDRA preserves the original cellular composition of the organ of interest, it is ideal for testing novel IO therapies incl. CPI and ADC.
Fraunhofer Institute for Toxicology and Experimental Medicine